Actively Recruiting
Glofitamab in Real Life
Led by The Lymphoma Academic Research Organisation · Updated on 2026-01-14
250
Participants Needed
30
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To date, more than 300 patients have been treated with Glofitamab in the Expanded Access Programme (EAP) in France. In this study, it is proposed to perform a retrospective analysis of some of these patients. The aim is to describe the efficacy and safety of Glofitamab in the largest reported real-world cohort, with an expected median follow-up of more than 9 months. Particular focus will be given to the relapsed or refractory chimeric antigen receptors-T (CAR-T) population to confirm the response rates (CRR: 35-39%) of Glofitamab in this population and to assess the optimal timing of therapy initiation \[8, 15\].
CONDITIONS
Official Title
Glofitamab in Real Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient enrolled in the French Glofitamab Expanded Access Programme for relapsed or refractory DLBCL before November 1, 2024
- Patient who received at least Obinutuzumab pretreatment and one infusion of Glofitamab
- Adult patient
- Patient informed of the study and who did not oppose data collection
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 30 locations
1
CH Victor Dupouy
Argenteuil, France, 95100
Actively Recruiting
2
CH d'Avignon - Hôpital Henri Dufaut
Avignon, France, 84000
Actively Recruiting
3
CH de la Côte Basque
Bayonne, France
Actively Recruiting
4
CHRU Besançon - Hôpital Minjoz
Besançon, France
Actively Recruiting
5
Hopital D'Instruction Des Armees Percy
Clamart, France, 92141
Actively Recruiting
6
Hopital Henri Mondor
Créteil, France
Actively Recruiting
7
CHU de Dijon - Hôpital le Bocage
Dijon, France, 21000
Actively Recruiting
8
CH de Dunkerque
Dunkirk, France
Actively Recruiting
9
CHU de Grenoble - Hôpital Albert Michallon
La Tronche, France
Actively Recruiting
10
Hôpital de Libourne
Libourne, France
Actively Recruiting
11
CHRU de LILLE - Claude Huriez
Lille, France
Actively Recruiting
12
Hopital Saint Vincent-de-Paul
Lille, France
Actively Recruiting
13
Centre Léon Bérard
Lyon, France, 69373
Actively Recruiting
14
INSTITUT PAOLI CALMETTES - Service Hématologie
Marseille, France
Actively Recruiting
15
Clinique du Pont de Chaume
Montauban, France
Actively Recruiting
16
CH de Mulhouse Sud Alsace
Mulhouse, France, 68070
Actively Recruiting
17
CHR d'Orléans
Orléans, France
Actively Recruiting
18
Hopital Saint-Louis
Paris, France
Actively Recruiting
19
Chu de Bordeaux - Hopital Haut-Leveque
Pessac, France
Actively Recruiting
20
CHU Lyon Sud
Pierre-Bénite, France
Actively Recruiting
21
CHU de Poitiers - Hôpital de La Milétrie
Poitiers, France
Actively Recruiting
22
CH de Quimper Cornouaille
Quimper, France, 29107
Actively Recruiting
23
CHU de Rennes - Hôpital de Pontchaillou
Rennes, France
Actively Recruiting
24
Institut Curie - Site Saint-Cloud
Saint-Cloud, France
Actively Recruiting
25
CHU de Strasbourg
Strasbourg, France
Actively Recruiting
26
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Actively Recruiting
27
Chu Bretonneau
Tours, France
Actively Recruiting
28
CHRU de Nancy - Hôpital de Brabois
Vandœuvre-lès-Nancy, France
Actively Recruiting
29
Ch de Bretagne Atlantique
Vannes, France
Actively Recruiting
30
Gustave Roussy Cancer Campus Grand Paris
Villejuif, France
Actively Recruiting
Research Team
P
PROJECT MANAGER
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here